As one of the world’s leading specialty biopharmaceutical companies, Shire
has emerged as a company fully focused on a single purpose: to enable
people with life-altering conditions to lead better lives.
Through our Shire Human Genetic Therapies business we pursue treatment
opportunities on behalf of patients and families facing rare diseases such as
Fabry Disease, a lysosomal storage disorder and hereditary angioedema - patients
whose lives and well being often hinge on the discovery and delivery of critical
Through our Specialty Pharma business we develop and distribute an
innovative portfolio of treatments for patients with ADHD, ulcerative colitis,
and end-stage renal disease. Our commitment throughout is on symptomatic
diseases, treated by specialist physicians.
Strategic partnerships have fueled Shire’s rapid growth—acquisitions and mergers
designed to fortify development as well as marketed portfolios. In the
twenty plus years of Shire’s short history, the majority of our new products
have joined our stable of existing medicines via an acquisition or partnership.
The only exception being our HGT business, where development of enzyme
replacement therapies from early phases is lower risk than the discovery of
small molecules and we have an active in-house early research capability.
At the same time, Shire has systematically extended its global reach by building
operations in other global locations. By offering a range of essential
medicines to patients all over the world, Shire has gained a reputation as a
company that delivers on the promises it makes.
We also care, at Shire,
about the communities in which we live and work—about who we are and the legacy
we leave behind. Through countless Corporate Responsibility initiatives,
we’re making a difference by supporting programs ranging from the education of
young scientists and the beautifying of natural landscapes to the reduction of
CO2 emissions and the development of a green-oriented employee family.
Shire we are perpetually planning for the future. We’re exploring new markets.
We’re conversing with thought leaders. We’re listening to patients and
families, to innovators and inventors. We’re asking ourselves what more we can
do to make this world a healthier place and in doing so, we’re mindful of our
overall cultural ethos; to be as brave as the people we help.
To learn more,
please visit the Shire Corporate website at